ArticleBMC cancer2023

Personalized follow-up of circulating DNA in resected stage III/IV melanoma: PERCIMEL multicentric prospective study protocol.

Lionnel Geoffrois et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.